MMayo Clinic Proceedings3/1/2026Fulminant Type 1 Diabetes Mimicry: “Pseudo-hyperglycemia” Due to Upstream Blood Sampling in a Patient Receiving Immune Checkpoint Inhibitor TherapyHiroya Kitsunai·Hiroshi Nomoto·Takao Takiyama·Fumio MaruyamaRead at Mayo Clinic ProceedingsTagsDiabetes and associated disordersGenetics
